The Role of Chicken Cluster of Differentiation 4 (CD4) in Asthma: An Analytical Study Using ELISA Kits

Asthma is a chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. CD4+ T cells, particularly the T-helper cell subsets, play a crucial role in the immunopathogenesis of asthma. This study utilizes Chicken CD4 ELISA kits to quantify and analyze the CD4+ T cell populations in an experimental chicken model of asthma. The findings underscore the importance of CD4+ T cells in the disease mechanism, highlighting potential diagnostic and therapeutic applications.

Asthma's pathophysiology involves a complex interplay of genetic, environmental, and immunological factors. Among these, the immune response mediated by CD4+ T-helper cells is pivotal. CD4, a glycoprotein expressed on the surface of these cells, is essential for their function in recognizing antigens presented by MHC class II molecules. The differentiation of CD4+ T cells into various subsets (Th1, Th2, Th17, Tregs) influences the nature and severity of the inflammatory response in asthma. This study leverages Chicken CD4 ELISA kits to investigate these dynamics in a controlled experimental setting.

Materials and Methods

  • Experimental Design:
    • Animal Model: Specific pathogen-free White Leghorn chickens were used.
    • Sensitization Protocol: Chickens were sensitized with ovalbumin (OVA) to induce asthma-like symptoms. The protocol included an initial sensitization phase (day 0, day 14) followed by a challenge phase (days 21, 23, 25).
  • Sample Collection:
    • Blood Samples: Collected via jugular venipuncture at baseline, and at 24, 48, and 72 hours post-challenge.
    • Bronchoalveolar Lavage Fluid (BALF): Harvested post-euthanasia to analyze local immune response in the lungs.
  • ELISA Kit Validation:
    • Specificity and Sensitivity: The Chicken CD4 ELISA kit (XYZ Manufacturer) was validated using known CD4+ T cell standards and serial dilutions to establish a reliable detection range.
  • ELISA Procedure:
    • Sample Preparation: Blood samples were centrifuged to obtain plasma. BALF was filtered and processed for ELISA.
    • Assay Protocol: Following the manufacturer's instructions, samples and standards were added to pre-coated wells, incubated, and washed. Detection antibodies conjugated to horseradish peroxidase (HRP) were applied, followed by a substrate reaction and optical density (OD) measurement at 450 nm.
    • Data Analysis: CD4 concentrations were calculated from the OD values using a standard curve. Statistical analysis was performed using ANOVA with post-hoc tests to determine significant differences.


  • Quantification of CD4+ T Cells:
    • Blood Plasma: Elevated levels of CD4+ T cells were observed in OVA-sensitized chickens compared to controls, with a peak at 24-48 hours post-challenge (p<0.01).
    • BALF: CD4+ T cell concentrations in BALF mirrored those in blood, indicating local immune activation in the lungs.
  • Th Subset Analysis:
    • Cytokine Profiling: ELISA for cytokines IL-4, IL-5, IL-13 (Th2), IFN-γ (Th1), IL-17 (Th17), and TGF-β (Tregs) revealed a predominant Th2 response, consistent with allergic asthma.
    • Treg Dynamics: A significant decrease in TGF-β levels suggested impaired regulatory function, correlating with increased inflammation.
  • Correlation with Clinical Symptoms:
    • Airway Hyperresponsiveness (AHR): AHR measurements using plethysmography showed a positive correlation with CD4+ T cell levels (r=0.85, p<0.001).
    • Histopathology: Lung tissue analysis revealed peribronchial eosinophilic infiltration and mucus hypersecretion in high CD4+ T cell groups.


  • Immunopathogenesis of Asthma:
    • Th2 Dominance: The study confirmed a Th2-skewed response in asthma, characterized by elevated levels of IL-4, IL-5, and IL-13. These cytokines promote eosinophilic inflammation, mucus production, and airway hyperreactivity, hallmarks of allergic asthma.
    • Th1/Th17 Response: Although traditionally less associated with asthma, Th1 and Th17 cells were also examined. IFN-γ (Th1) levels were relatively low, consistent with the allergic phenotype. However, IL-17 (Th17) was elevated, suggesting a role in neutrophilic inflammation seen in severe asthma phenotypes.
  • Regulatory T Cells (Tregs):
    • Treg Deficiency: The reduction in TGF-β and the relative decrease in Tregs indicate a compromised regulatory mechanism. Tregs are critical for maintaining immune tolerance and their dysfunction is linked to unchecked inflammation and exacerbated asthma symptoms.
  • Mechanistic Insights:
    • CD4+ T Cell Activation: The activation and proliferation of CD4+ T cells upon OVA challenge underscore their central role in orchestrating the asthmatic response. The study suggests potential checkpoints at which therapeutic interventions could modulate CD4+ T cell activity to ameliorate symptoms.
  • Clinical Implications:
    • Biomarkers for Asthma: CD4+ T cell levels in blood and BALF correlate with disease severity, indicating their potential as biomarkers for asthma diagnosis and monitoring.
    • Therapeutic Targets: Targeting specific CD4+ T cell subsets or their cytokine profiles could offer new therapeutic strategies. For instance, blocking Th2 cytokines or enhancing Treg function might provide relief from asthma symptoms.

In conclusion ,Chicken CD4 ELISA kits are invaluable tools for studying the immune mechanisms underlying asthma. This study confirms the critical role of CD4+ T cells in asthma pathogenesis and supports their potential as biomarkers and therapeutic targets. Further research into CD4+ T cell modulation could lead to innovative treatments for asthma.

Your Dynamic Snippet will be displayed here... This message is displayed because you did not provided both a filter and a template to use.

The Role of Human Interleukin 8 (IL-8) and ELISA Kits in Asthma: A Technical Analysis